Panel Interviews



















NEW YORK (TheStreet) -- Alkermes Plc* (ALKS) has been downgraded by TheStreet Ratings from Hold to Sell with a ratings score of D+. *TheStreet Ratings Team has this to say about their recommendation:

Stocks up 70% in last 6 mos. Analysts ratings are a 12 mo forecast on stock price...of course your gonna get one firm that says sell, 2 or 3 that say hold, and 1 or 2 that say buy...nature of the beast. If you can't handle the ups and downs of the market then maybe you should keep it in your piggy bank. Bottom line is that you join a company based on the future beyond just a 12 MO forecast and this seems to be a promising organization.
 






























Wow, requiring CNS experience to sell a CNS drug-that's a new concept? How could they? Let's be real-all things being equal the candidate with more significant CNS experience will win.
 


































































Panel Interviews for the South in Atlanta this week, looking forward to closing this deal and working for a great company. And I could care less if they have a fleet car or not, I would rather drive what I want but either way this is going to be a great gig.